SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : HuMAB companies -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (145)4/17/2001 12:37:05 PM
From: scaram(o)uche  Read Replies (1) | Respond to of 1022
 
This.......

``Like antibodies, fluorescent 'super' MIPs can be coated onto beads or
wells for use in highly sensitive separation or assay, or for use in high throughput screening of proteins. Simpler, less
expensive and more stable immunoassays for use in diagnostic tests may be developed, as can new generations of
orally available therapeutics which act solely to rapidly absorb targeted substances in the gastrointestinal tract.''

seems like a reasonable list of expectations, to me.

>> Or a real threat to currently public companies? <<

Nah.



To: tuck who wrote (145)4/17/2001 2:56:31 PM
From: jayhawk969  Respond to of 1022
 
Tuck,

Tommysdad may have some thoughts on this. It makes since, chemically, that it would be cheaper and easier. The binding mechanism is less understood by me. If it binds more efficiently it starts to make sense. To me it parallels the development of natural rubber leading to the development of synthetic rubber.

J.D.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News